Tsumura & Co operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Tsumura & Co with three other
companies in this sector in Japan:
KYORIN Holdings, Incorporation
sales of 115.37 billion Japanese Yen [US$1.08 billion]
of which 95%
was Pharmaceutical Business),
Kaken Pharmaceutical Co Ltd
(101.48 billion Japanese Yen [US$946.80 million]
of which 98%
was Pharmaceutical), and
Nippon Shinyaku Co Ltd
(98.78 billion Japanese Yen [US$921.63 million]
of which 86%
was Pharmaceutical Products).
Tsumura & Co reported sales of ¥114.95 billion (US$1.07 billion)
March of 2017.
increase of 2.1%
versus 2016, when the company's sales were ¥112.63 billion.
Sales at Tsumura & Co have increased during each of the previous five years
(and since 2012, sales have increased a total of 20%).